Skip to main content
Stem Cell Therapy for Metabolic & Organ Regeneration
6 Treatments Available

Stem Cell Therapy for Metabolic & Organ Regeneration

Stem cell treatments targeting metabolic disorders and organ repair. Our protocols address diabetes, liver disease, kidney conditions, and pulmonary disorders through cellular regeneration.

Quick Summary

  • MSC therapy is studied for its effect on liver, kidney and pancreatic tissue
  • Studied in diabetes, hepatitis, liver disease, COPD, pulmonary fibrosis, and kidney disease
  • IV and targeted delivery protocols for organ-specific stem cell migration
  • All-inclusive packages from €5,900 including GMP lab, JCI hospital, and accommodation
  • Patients report improved organ function markers and reduced medication dependency

Conditions We Treat

Click any condition below to learn about our specific stem cell protocol, success rates, and treatment process.

Cost Comparison: Turkey vs. Abroad

Best Value

Turkey (Istanbul)

€5,900–€11,000

All-inclusive: hotel, transfers, labs

United States

$20,000–$65,000

Treatment only, excludes travel

United Kingdom

£14,000–£40,000

Treatment only, excludes travel

Save 60-80% on equivalent stem cell treatments compared to the US and UK.

Why Choose Istanbul for Metabolic & Organ Regeneration Treatment?

GMP-Certified Laboratory

All stem cells processed in ISO-certified, GMP-compliant clean room facilities

JCI-Accredited Hospital

Treatments administered at internationally accredited hospitals with full emergency support

65% Improved Organ Function Markers

Based on published outcomes and patient-reported improvements across protocols

All-Inclusive Packages

Hotel, airport transfers, medical coordinator, post-treatment follow-up included

Frequently Asked Questions

MSCs promote tissue repair by reducing inflammation, stimulating resident stem cells, and supporting new tissue formation. Clinical evidence shows improvements in liver function, kidney markers, and metabolic parameters.

MSC therapy can improve insulin sensitivity, reduce HbA1c levels, and decrease insulin requirements. Type 2 diabetes patients generally respond best, though Type 1 protocols targeting autoimmune modulation are also available.

Treatment packages range from €6,950 to €12,000, which is 60-75% less than equivalent treatments in the US ($20,000-$65,000). All-inclusive pricing covers GMP lab, JCI hospital, specialist consultations, hotel, and transfers.

Yes. MSCs can reduce liver fibrosis, improve liver function markers (ALT, AST, albumin), and support hepatocyte regeneration. They are effective for hepatitis-related damage, fatty liver disease, and early-stage cirrhosis.

MSC therapy can reduce pulmonary inflammation, improve lung function parameters (FEV1, FVC), and decrease exacerbation frequency in COPD patients. Results are typically noticeable within 3-6 months of treatment.

Most patients experience benefits lasting 12-24 months. Lifestyle modifications and follow-up care can extend these benefits. Some patients elect for maintenance sessions annually to sustain improvements.

Ready to Explore Your Options?

Schedule a free consultation with our medical team. We'll review your condition and create a personalized treatment plan.

International Patient Coordination

StemCell Longevita operates as an international patient coordination platform. We connect patients with licensed medical institutions that provide regenerative medicine applications following physician evaluation and applicable regulatory frameworks. All medical decisions and procedures are conducted exclusively by authorized healthcare professionals. StemCell Longevita does not directly provide medical treatment.

Medical Disclaimer

The information provided on this website is for educational and informational purposes only and is not intended as medical advice. Stem cell therapy is an evolving field, and outcomes may vary by individual. The treatments described on this site have not been fully evaluated or approved by the FDA or equivalent regulatory bodies in all jurisdictions.

The FDA has not approved stem cell applications for most conditions listed on this website. Results mentioned are based on clinical observations, published research, and patient-reported outcomes. Individual results may vary and no specific outcomes are assured for any individual patient.

Inclusion of scientific publications on this website does not imply regulatory approval, and does not imply any clinical outcome for an individual patient. Certain applications may be considered investigational depending on indication and jurisdiction.

Always consult with a qualified healthcare professional before making any medical decisions. Do not disregard professional medical advice or delay seeking treatment based on information found on this website.